Griffin Asset Management, Inc. Summit Therapeutics Inc. Transaction History
Griffin Asset Management, Inc.
- $799 Million
- Q1 2025
A detailed history of Griffin Asset Management, Inc. transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Griffin Asset Management, Inc. holds 117,210 shares of SMMT stock, worth $3.06 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
117,210
Previous 110,660
5.92%
Holding current value
$3.06 Million
Previous $1.98 Million
14.43%
% of portfolio
0.28%
Previous 0.24%
Shares
3 transactions
Others Institutions Holding SMMT
# of Institutions
231Shares Held
83.1MCall Options Held
1.66MPut Options Held
2.56M-
Baker Bros. Advisors LP New York, NY24.4MShares$638 Million4.83% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$305 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$206 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.56MShares$171 Million0.01% of portfolio
-
State Street Corp Boston, MA5.6MShares$146 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $5.26B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...